Arsenic modifies the effect of folic acid in spina bifida prevention, a large hospital-based case-control study in Bangladesh.
Arsenic
Bangladesh
Folic acid
Spina bifida
Journal
Environmental health : a global access science source
ISSN: 1476-069X
Titre abrégé: Environ Health
Pays: England
ID NLM: 101147645
Informations de publication
Date de publication:
03 Jun 2024
03 Jun 2024
Historique:
received:
25
02
2024
accepted:
19
05
2024
medline:
4
6
2024
pubmed:
4
6
2024
entrez:
3
6
2024
Statut:
epublish
Résumé
Spina bifida, a developmental malformation of the spinal cord, is associated with high rates of mortality and disability. Although folic acid-based preventive strategies have been successful in reducing rates of spina bifida, some areas continue to be at higher risk because of chemical exposures. Bangladesh has high arsenic exposures through contaminated drinking water and high rates of spina bifida. This study examines the relationships between mother's arsenic exposure, folic acid, and spina bifida risk in Bangladesh. We conducted a hospital-based case-control study at the National Institute of Neurosciences & Hospital (NINS&H) in Dhaka, Bangladesh, between December 2016 and December 2022. Cases were infants under age one year with spina bifida and further classified by a neurosurgeon and imaging. Controls were drawn from children seen at NINS&H and nearby Dhaka Shishu Hospital. Mothers reported folic acid use during pregnancy, and we assessed folate status with serum assays. Arsenic exposure was estimated in drinking water using graphite furnace atomic absorption spectrophotometry (GF-AAS) and in toenails using inductively coupled plasma mass spectrometry (ICP-MS). We used logistic regression to examine the associations between arsenic and spina bifida. We used stratified models to examine the associations between folic acid and spina bifida at different levels of arsenic exposure. We evaluated data from 294 cases of spina bifida and 163 controls. We did not find a main effect of mother's arsenic exposure on spina bifida risk. However, in stratified analyses, folic acid use was associated with lower odds of spina bifida (adjusted odds ratio [OR]: 0.50, 95% confidence interval [CI]: 0.25-1.00, p = 0.05) among women with toenail arsenic concentrations below the median value of 0.46 µg/g, and no association was seen among mothers with toenail arsenic concentrations higher than 0.46 µg/g (adjusted OR: 1.09, 95% CI: 0.52-2.29, p = 0.82). Mother's arsenic exposure modified the protective association of folic acid with spina bifida. Increased surveillance and additional preventive strategies, such as folic acid fortification and reduction of arsenic, are needed in areas of high arsenic exposure.
Sections du résumé
BACKGROUND
BACKGROUND
Spina bifida, a developmental malformation of the spinal cord, is associated with high rates of mortality and disability. Although folic acid-based preventive strategies have been successful in reducing rates of spina bifida, some areas continue to be at higher risk because of chemical exposures. Bangladesh has high arsenic exposures through contaminated drinking water and high rates of spina bifida. This study examines the relationships between mother's arsenic exposure, folic acid, and spina bifida risk in Bangladesh.
METHODS
METHODS
We conducted a hospital-based case-control study at the National Institute of Neurosciences & Hospital (NINS&H) in Dhaka, Bangladesh, between December 2016 and December 2022. Cases were infants under age one year with spina bifida and further classified by a neurosurgeon and imaging. Controls were drawn from children seen at NINS&H and nearby Dhaka Shishu Hospital. Mothers reported folic acid use during pregnancy, and we assessed folate status with serum assays. Arsenic exposure was estimated in drinking water using graphite furnace atomic absorption spectrophotometry (GF-AAS) and in toenails using inductively coupled plasma mass spectrometry (ICP-MS). We used logistic regression to examine the associations between arsenic and spina bifida. We used stratified models to examine the associations between folic acid and spina bifida at different levels of arsenic exposure.
RESULTS
RESULTS
We evaluated data from 294 cases of spina bifida and 163 controls. We did not find a main effect of mother's arsenic exposure on spina bifida risk. However, in stratified analyses, folic acid use was associated with lower odds of spina bifida (adjusted odds ratio [OR]: 0.50, 95% confidence interval [CI]: 0.25-1.00, p = 0.05) among women with toenail arsenic concentrations below the median value of 0.46 µg/g, and no association was seen among mothers with toenail arsenic concentrations higher than 0.46 µg/g (adjusted OR: 1.09, 95% CI: 0.52-2.29, p = 0.82).
CONCLUSIONS
CONCLUSIONS
Mother's arsenic exposure modified the protective association of folic acid with spina bifida. Increased surveillance and additional preventive strategies, such as folic acid fortification and reduction of arsenic, are needed in areas of high arsenic exposure.
Identifiants
pubmed: 38831396
doi: 10.1186/s12940-024-01091-1
pii: 10.1186/s12940-024-01091-1
doi:
Substances chimiques
Folic Acid
935E97BOY8
Arsenic
N712M78A8G
Water Pollutants, Chemical
0
Drinking Water
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
51Subventions
Organisme : NIMH NIH HHS
ID : T32 MH112510
Pays : United States
Organisme : NIEHS NIH HHS
ID : R01 ES026317
Pays : United States
Informations de copyright
© 2024. The Author(s).
Références
Iskandar BJ, Finnell RH. Spina Bifida. N Engl J Med. 2022;387(5):444–50.
doi: 10.1056/NEJMra2116032
Blencowe H, Kancherla V, Moorthie S, Darlison MW, Modell B. Estimates of global and regional prevalence of neural tube defects for 2015: a systematic analysis. Ann N Y Acad Sci. 2018;1414(1):31–46.
doi: 10.1111/nyas.13548
De-Regil LM, Pena-Rosas JP, Fernandez-Gaxiola AC, Rayco-Solon P. Effects and safety of periconceptional oral folate supplementation for preventing birth defects. Cochrane Database Syst Rev. 2015;2015(12):CD007950.
Castillo-Lancellotti C, Tur JA, Uauy R. Impact of folic acid fortification of flour on neural tube defects: a systematic review. Public Health Nutr. 2013;16(5):901–11.
doi: 10.1017/S1368980012003576
Atta CA, Fiest KM, Frolkis AD, Jette N, Pringsheim T, St Germaine-Smith C, Rajapakse T, Kaplan GG, Metcalfe A. Global birth prevalence of spina bifida by folic acid fortification status: a systematic review and meta-analysis. Am J Public Health. 2016;106(1):e24–34.
doi: 10.2105/AJPH.2015.302902
Cordero A, Mulinare J, Berry RJ, Boyle C, Dietz W, Johnston R Jr., Popovic T. CDC grand rounds: additional opportunities to prevent neural tube defects with folic acid fortification. Morb Mortal Wkly Rep. 2010;59(31):980–4.
Wlodarczyk BJ, Bennett GD, Calvin JA, Finnell RH. Arsenic-induced neural tube defects in mice: alterations in cell cycle gene expression. Reprod Toxicol. 1996;10(6):447–54.
doi: 10.1016/S0890-6238(96)00131-1
Hill DS, Wlodarczyk BJ, Finnell RH. Reproductive consequences of oral arsenate exposure during pregnancy in a mouse model. Birth Defects Res Part B: Dev Reproductive Toxicol. 2008;83(1):40–7.
doi: 10.1002/bdrb.20142
Hood RD, Bishop SL. Teratogenic effects of sodium arsenate in mice. Arch Environ Health. 1972;24(1):62–5.
doi: 10.1080/00039896.1972.10666051
Beaudoin AR. Teratogenicity of sodium arsenate in rats. Teratology. 1974;10(2):153–7.
doi: 10.1002/tera.1420100211
Carpenter SJ. Developmental analysis of cephalic axial dysraphic disorders in arsenic-treated hamster embryos. Anat Embryol (Berl). 1987;176(3):345–65.
doi: 10.1007/BF00310189
Abuawad A, Bozack AK, Saxena R, Gamble MV. Nutrition, one-carbon metabolism and arsenic methylation. Toxicology. 2021;457:152803.
doi: 10.1016/j.tox.2021.152803
Eaves LA, Choi G, Hall E, Sille FCM, Fry RC, Buckley JP, Keil AP. Prenatal exposure to toxic metals and neural tube defects: a systematic review of the epidemiologic evidence. Environ Health Perspect. 2023;131(8):86002.
doi: 10.1289/EHP11872
Chakraborti D, Rahman MM, Mukherjee A, Alauddin M, Hassan M, Dutta RN, Pati S, Mukherjee SC, Roy S, Quamruzzman Q, et al. Groundwater arsenic contamination in bangladesh-21 years of research. J Trace Elem Med Biol. 2015;31:237–48.
doi: 10.1016/j.jtemb.2015.01.003
Smith AH, Lingas EO, Rahman M. Contamination of drinking-water by arsenic in Bangladesh: a public health emergency. Bull World Health Organ. 2000;78(9):1093–103.
Bangladesh Bureau of Statistics (BBS) and, Bangladesh UNICEF. Progotir pathey, Bangladesh multiple indicator cluster survey 2019, survey findings report. Bangladesh Bureau of Statistics (BBS). 2019.
Shuma ML, Halder S, Datta BK. Epidemiology of congenital anomalies among the children born in different hospitals under sylhet division in Bangladesh - a retrospective study. Dhaka Univ J PharSci. 2015;14(2):225–30.
doi: 10.3329/dujps.v14i2.28514
Dey AC, Shahidullah M, Mannan MA, Noor MK, Saha L, Rahman SA. Maternal and neonatal serum zinc level and its relationship with neural tube defects. J Health Popul Nutr. 2010;28(4):343–50.
doi: 10.3329/jhpn.v28i4.6040
Mazumdar M, Ibne Hasan MO, Hamid R, Valeri L, Paul L, Selhub J, Rodrigues EG, Silva F, Mia S, Mostofa MG, et al. Arsenic is associated with reduced effect of folic acid in myelomeningocele prevention: a case control study in Bangladesh. Environ Health. 2015;14(1):34.
doi: 10.1186/s12940-015-0020-0
Tindula G, Mukherjee SK, Ekramullah SM, Arman DM, Biswas SK, Islam J, Obrycki JF, Christiani DC, Liang L, Warf BC, et al. Parental metal exposures as potential risk factors for spina bifida in Bangladesh. Environ Int. 2021;157:106800.
doi: 10.1016/j.envint.2021.106800
Gamboa-Loira B, Cebrian ME, Franco-Marina F, Lopez-Carrillo L. Arsenic metabolism and cancer risk: a meta-analysis. Environ Res. 2017;156:551–8.
doi: 10.1016/j.envres.2017.04.016
Mazumdar M. Does arsenic increase the risk of neural tube defects among a highly exposed population? A new case-control study in Bangladesh. Birth Defects Res. 2017;109(2):92–8.
doi: 10.1002/bdra.23577
Chen Y, Ahsan H, Parvez F, Howe GR. Validity of a food-frequency questionnaire for a large prospective cohort study in Bangladesh. Br J Nutr. 2004;92(5):851–9.
doi: 10.1079/BJN20041277
Frisbie SH, Mitchell EJ, Yusuf AZ, Siddiq MY, Sanchez RE, Ortega R, Maynard DM, Sarkar B. The development and use of an innovative laboratory method for measuring arsenic in drinking water from western Bangladesh. Environ Health Perspect. 2005;113(9):1196–204.
doi: 10.1289/ehp.7974
Chen KL, Amarasiriwardena CJ, Christiani DC. Determination of total arsenic concentrations in nails by inductively coupled plasma mass spectrometry. Biol Trace Elem Res. 1999;67(2):109–25.
doi: 10.1007/BF02784067
Copp AJ, Greene ND. Neural tube defects–disorders of neurulation and related embryonic processes. Wiley Interdiscip Rev Dev Biol. 2013;2(2):213–27.
doi: 10.1002/wdev.71
Kancherla V, Ibne Hasan MOS, Hamid R, Paul L, Selhub J, Oakley G, Quamruzzaman Q, Mazumdar M. Prenatal folic acid use associated with decreased risk of myelomeningocele: a case-control study offers further support for folic acid fortification in Bangladesh. PLoS ONE. 2017;12(11):e0188726.
doi: 10.1371/journal.pone.0188726
Khambalia A, O’Connor DL, Zlotkin S. Periconceptional iron and folate status is inadequate among married, nulliparous women in rural Bangladesh. J Nutr. 2009;139(6):1179–84.
doi: 10.3945/jn.108.101022
Alam N, Roy SK, Ahmed T, Ahmed AM. Nutritional status, dietary intake, and relevant knowledge of adolescent girls in rural Bangladesh. J Health Popul Nutr. 2010;28(1):86–94.
doi: 10.3329/jhpn.v28i1.4527
Rodrigues EG, Kile M, Dobson C, Amarasiriwardena C, Quamruzzaman Q, Rahman M, Golam M, Christiani DC. Maternal-infant biomarkers of prenatal exposure to arsenic and manganese. J Expo Sci Environ Epidemiol. 2015;25(6):639–48.
doi: 10.1038/jes.2015.45
Pi X, Wang C, Yin S, Jin L, Li Z, Wang L, Liu J, Zhang Y, Ren A. Arsenic exposure, periconceptional folic acid supplementation, and the risk for neural tube defects: a case–control study. Exposure Health. 2022;15(1):245–54.
doi: 10.1007/s12403-022-00487-z
Wlodarczyk BJ, Cabrera RM, Hill DS, Bozinov D, Zhu H, Finnell RH. Arsenic-induced gene expression changes in the neural tube of folate transport defective mouse embryos. Neurotoxicology. 2006;27(4):547–57.
doi: 10.1016/j.neuro.2006.02.005
Han ZJ, Song G, Cui Y, Xia HF, Ma X. Oxidative stress is implicated in arsenic-induced neural tube defects in chick embryos. Int J Dev Neurosci. 2011;29(7):673–80.
doi: 10.1016/j.ijdevneu.2011.06.006
Gamble MV, Liu X, Ahsan H, Pilsner JR, Ilievski V, Slavkovich V, Parvez F, Chen Y, Levy D, Factor-Litvak P, et al. Folate and arsenic metabolism: a double-blind, placebo-controlled folic acid-supplementation trial in Bangladesh. Am J Clin Nutr. 2006;84(5):1093–101.
doi: 10.1093/ajcn/84.5.1093
Gamble MV, Liu X, Slavkovich V, Pilsner JR, Ilievski V, Factor-Litvak P, Levy D, Alam S, Islam M, Parvez F, et al. Folic acid supplementation lowers blood arsenic. Am J Clin Nutr. 2007;86(4):1202–9.
doi: 10.1093/ajcn/86.4.1202
Peters BA, Hall MN, Liu X, Parvez F, Sanchez TR, van Geen A, Mey JL, Siddique AB, Shahriar H, Uddin MN, et al. Folic acid and creatine as therapeutic approaches to lower blood arsenic: a randomized controlled trial. Environ Health Perspect. 2015;123(12):1294–301.
doi: 10.1289/ehp.1409396
Demir N, Başaranoğlu M, Huyut Z, Değer İ, Karaman K, Şekeroğlu MR, Tuncer O. The relationship between mother and infant plasma trace element and heavy metal levels and the risk of neural tube defect in infants. J Maternal-Fetal Neonatal Med. 2019;32(9):1433–40.
doi: 10.1080/14767058.2017.1408064
Leung M, Kioumourtzoglou MA, Raz R, Weisskopf MG. Bias due to selection on live births in studies of environmental exposures during pregnancy: a simulation study. Environ Health Perspect. 2021;129(4):47001.
doi: 10.1289/EHP7961
Signes-Pastor AJ, Gutierrez-Gonzalez E, Garcia-Villarino M, Rodriguez-Cabrera FD, Lopez-Moreno JJ, Varea-Jimenez E, Pastor-Barriuso R, Pollan M, Navas-Acien A, Perez-Gomez B, et al. Toenails as a biomarker of exposure to arsenic: a review. Environ Res. 2021;195:110286.
doi: 10.1016/j.envres.2020.110286
Wallingford JB, Niswander LA, Shaw GM, Finnell RH. The continuing challenge of understanding, preventing, and treating neural tube defects. Science. 2013;339(6123):1222002.
doi: 10.1126/science.1222002